Abdenour Bounihi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdenour Bounihi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Asma Bouazza
Houari Boumediene University of Sciences and Technology (USTHB), Bab Ezzouar, 16123, Algiers, Algeria, University of Sciences and Technology Houari Boumediene, Algiers, Algeria, Algeria
1 shared publication - Aziz Hichami
Physiologie de Nutrition & Toxicology (NUTox), UMR UB/INSERM 1231 Center for Cellular & Translational Molecular Medicine (CTM), Université Bourgogne Europe, Dijon, France
1 shared publication - Elhadj-Ahmed Koceir
University of Sciences and Technology Houari Boumediene, Algiers, Algeria, Algeria
1 shared publication - Hamza Saidi
Department of Biology and Organism Physiology, University of Sciences and Technology Houari Boumediene, Algiers, Algeria, Algeria
1 shared publication - Ines Gouaref
Bioenergetics and Intermediary Metabolism Team, Department of Biology and Organism Physiology, Faculty of Biological Sciences, Houari Boumediene University of Sciences and Technology, Algiers 16111, Algeria
1 shared publication - Naim Akhtar Khan
Team-Physiologie de la Nutrition & Toxicologie, INSERM, CTM UMR U1231, Université Bourgogne Europe, 21000 Dijon, France
1 shared publication
Latest Publications
- Open Access
- 2 July 2026
- Published by MDPI AG in Preprints.org
Fruits Vinegars as Dietary Emerging Therapies in Obesity and Diabetes: Interest on Special Reference to Pomegranate Versus Prickly Pear and Apple Vinegars
Background/objective: This in vivo and in vitro studies aims to test the hypothesis that functional foods represented by fruit vinegars (FVs) can be an alternative dietary treatment for body weight loss in obesity, and metabolic syndrome/inflammation complications can lead to the diabetes development. Methods: In vivo experiment was carried on Wistar rat, Sprague Dawley strain, divided into 04 groups including n=30 rats/group: i) Group I or Control group fed the standard laboratory diet; ii) Group II or Control group, fed the HyperFat Diet (HFD); iii) Group III or therapeutic group, fed HFD and treated separately with pomegranate or prickly pear or apple FVs by 7ml /kg body weight/day administered orally for 18 weeks; iv) Group IV or Placebo group, fed HFD and received orally 7ml of saline solution (0.09%) for 18 weeks. In vitro experiment was conducted on 3T3-preadipocytes cell line to study the anti-adipogenic effects, and on Raw 264,7 cell line to study the anti-inflammatory effects. Results: The major results reveal that FVs exerts a powerful body-fat loss linked to fat oxidation, sustained by RQ=0.7 and increase BMR, associated with elevated serum free fatty acids, which confirms lipolytic activity. Among the 3 vinegars, pomegranate vinegar showed the greatest health benefit; however, hepatic steatosis and dyslipidemia were normalized by apple vinegar, which has proven to be the most effective. FVs exerts a spectacular anti- obesogenic effect by inhibiting the differentiation of 3T3-preadipocytes into mature adipocytes; and by inhibiting the inflammatory-necrotic process via the suppression of cytokines TNFα, IL-6, IL-1β production. The PPARγ, C/EBPα and NF-κB modulation signaling pathways is convincing. Conclusions: the data from this study are considered a preclinical phase with potential translational relevance, but not clinical recommendations. Ultimately, Fruit vinegars represent an emerging therapeutic prospective as functional foods, thus justifying further human clinical research.
- 2 July 2026
- Published by MDPI AG in Preprints.org
Open AccessFruits Vinegars as Dietary Emerging Therapies in Obesity and Diabetes: Interest on Special Reference to Pomegranate Versus Prickly Pear and Apple Vinegars
Background/objective: This in vivo and in vitro studies aims to test the hypothesis that functional foods represented by fruit vinegars (FVs) can be an alternative dietary treatment for body weight loss in obesity, and metabolic syndrome/inflammation complications can lead to the diabetes development. Methods: In vivo experiment was carried on Wistar rat, Sprague Dawley strain, divided into 04 groups including n=30 rats/group: i) Group I or Control group fed the standard laboratory diet; ii) Group II or Control group, fed the HyperFat Diet (HFD); iii) Group III or therapeutic group, fed HFD and treated separately with pomegranate or prickly pear or apple FVs by 7ml /kg body weight/day administered orally for 18 weeks; iv) Group IV or Placebo group, fed HFD and received orally 7ml of saline solution (0.09%) for 18 weeks. In vitro experiment was conducted on 3T3-preadipocytes cell line to study the anti-adipogenic effects, and on Raw 264,7 cell line to study the anti-inflammatory effects. Results: The major results reveal that FVs exerts a powerful body-fat loss linked to fat oxidation, sustained by RQ=0.7 and increase BMR, associated with elevated serum free fatty acids, which confirms lipolytic activity. Among the 3 vinegars, pomegranate vinegar showed the greatest health benefit; however, hepatic steatosis and dyslipidemia were normalized by apple vinegar, which has proven to be the most effective. FVs exerts a spectacular anti- obesogenic effect by inhibiting the differentiation of 3T3-preadipocytes into mature adipocytes; and by inhibiting the inflammatory-necrotic process via the suppression of cytokines TNFα, IL-6, IL-1β production. The PPARγ, C/EBPα and NF-κB modulation signaling pathways is convincing. Conclusions: the data from this study are considered a preclinical phase with potential translational relevance, but not clinical recommendations. Ultimately, Fruit vinegars represent an emerging therapeutic prospective as functional foods, thus justifying further human clinical research.